一个调查性别不一致的欧洲网络 (ENIGI)
The physical and psychological effects of the hormonal treatment of transsexual persons are not sufficiently described. 'Transparency' wants to answer this question in a prospective manner, in a multicenter study to describe these effects. The low prevalence of transsexualism was the stimulus to search for European partners for this Protocol. A common standardized hormonal protocol was designed.
研究概览
地位
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Guy T'Sjoen, MD
- 邮箱:guy.tsjoen@ugent.be
学习地点
-
-
-
Florence、意大利
- 招聘中
-
接触:
- Alessandra Fisher, MD
-
首席研究员:
- Alessandra Fisher, MD
-
-
-
-
-
Oslo、挪威
- 招聘中
- Rikshospitalet University Hospital, University of Oslo
-
接触:
- Thomas Schreiner
- 邮箱:thomas.schreiner@rikshospitalet.no
-
首席研究员:
- Thomas Schreiner, MD
-
-
-
-
-
Ghent、比利时
- 招聘中
- Genderteam UZ Gent
-
接触:
- Guy T'Sjoen, MD
- 邮箱:guy.tsjoen@ugent.be
-
首席研究员:
- Guy T'Sjoen, MD
-
-
-
-
-
Amsterdam、荷兰
- 招聘中
- VU University Medical CenterAmsterdam
-
接触:
- Michael van Trotsenburg, MD
- 邮箱:m.vantrotsenburg@vumc.nl
-
首席研究员:
- Michael van Trotsenburg, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
transsexual persons older than 18 years, who are not yet treated with hormonal therapy
描述
Inclusion Criteria:
- Transsexual persons older then 18 years, who are not yet treated with hormonal therapy.
Exclusion Criteria:
-
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
变性人开始激素治疗
|
a descriptive questionnaire, SF-36, , bone questionnaires, Baecke physical activity questionnaire, voice evaluation LFT (AST, ALT), CRP, creatinine, glucose, Total Cholesterol, Triglycerides, HDL-CH, LDL-CH, 25OH vitamin D, PSA if> 45 years, Hematocrit, testosterone, sex hormone-binding globulin, free testosterone , oestradiol, prolactin, luteinizing hormone, TSH, androgeengevoeligheids test (CAG RL), oral glucose tolerance test height, weight, blood pressure, chestcircumference, waist circumference, grip strength, measuring 2 ° and 4 ° finger, and Ferriman Gallwey score Evaluation of the hair pattern, using the Leeds acne classification scale, acne scars through ECCA scale (échelle d'évaluation clinique des cicatrices d'acné), androgenetic alopecia, and sebummetrie PQCT scanner, BMD assessment |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
physical and psychological effects of the hormonal treatment of transsexual persons
大体时间:annually
|
evaluations will be done every 3 months the first year of therapy, every 6 months in the second year, and after sex reassignment surgery annually. |
annually
|
合作者和调查者
调查人员
- 首席研究员:Guy T'Sjoen, MD、University Hospital, Ghent
出版物和有用的链接
一般刊物
- Shadid S, Abosi-Appeadu K, De Maertelaere AS, Defreyne J, Veldeman L, Holst JJ, Lapauw B, Vilsboll T, T'Sjoen G. Effects of Gender-Affirming Hormone Therapy on Insulin Sensitivity and Incretin Responses in Transgender People. Diabetes Care. 2020 Feb;43(2):411-417. doi: 10.2337/dc19-1061. Epub 2019 Nov 18.
- Auer MK, Ebert T, Pietzner M, Defreyne J, Fuss J, Stalla GK, T'Sjoen G. Effects of Sex Hormone Treatment on the Metabolic Syndrome in Transgender Individuals: Focus on Metabolic Cytokines. J Clin Endocrinol Metab. 2018 Feb 1;103(2):790-802. doi: 10.1210/jc.2017-01559.
- Bultynck C, Pas C, Defreyne J, Cosyns M, den Heijer M, T'Sjoen G. Self-perception of voice in transgender persons during cross-sex hormone therapy. Laryngoscope. 2017 Dec;127(12):2796-2804. doi: 10.1002/lary.26716. Epub 2017 Jul 21.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.